AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00988975 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Insertion of pelvicol graft
Description: Pelvicol graft
Study NCT02490254 — intervention group
Intervention type: OTHER
Intervention: Surveillance card
Study NCT01860820 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Geko device
Study NCT00194714 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HER-2/neu Peptide Vaccine
Description: Given ID
Study NCT00194714 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00752284 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coronectomy
Description: Coronectomy Group. Removal of crown of lower wisdom tooth, trim down root below crestal bone and primary closure
Study NCT00752284 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Excision
Description: Total excision of lower third molar
Study NCT00112294 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel (Taxane)
Description: IV, 225 mg/m\^2
Study NCT00112294 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel (Taxane)
Description: IV, 75 mg/m\^2
Study NCT00112294 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: AUC=6, q 3 weeks (6 cycles maximum)
Study NCT00112294 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Description: Intravenous, 400 mg/m\^2, initial dose followed by 250 mg/m\^2, weekly starting on Week 2
Study NCT00654654 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Human Fibroblasts (azficel-T)
Description: 1. Collection of 3 mm biopsies~2. Two injection treatments of facial wrinkles and creases~3. Conduct of study assessments
Study NCT02714231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diclofenac sodium (cataflam)
Description: The patients in the study group will take one tablet of cataflam 50 mg 30 min before the scheduled time of the procedure
Study NCT02714231 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: hyoscine butyl bromide (buscopan)
Description: The patients in the study group will take one tablet of buscopan 10 mg 30 min before the scheduled time of the procedure
Study NCT04092920 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: laser and SLA
Description: ligible patients will be randomized to 2 groups control group will receive SLA surface treated implant to replace badly broken tooth immediately after extraction and a study group will receive laser surface treated implant to replace badly broken tooth immediately after extraction.~atraumatic extraction will be performed and socket will be examined for presence of bone dehesince or fenestration if no, implant will be placed immediately and a implant primary stability will be measured using an ISQ unit and recorded as base Line reading .~gingival former will be attached to the implant and removed at 2 ,4,8,12 week intervals to record ISQ readings.
Study NCT02924376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemigatinib
Description: Pemigatinibonce a day by mouth for 2 consecutive weeks and 1 week off therapy
Study NCT03804164 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Intervention
Description: Attend Emerging from the Haze psychoeducational sessions
Study NCT03804164 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT03804164 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT04203160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CPI 613
Description: Given intravenously
Study NCT04203160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Given intravenously
Study NCT04203160 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: Given intravenously
Study NCT04203160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given intravenously
Study NCT04203160 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Given intravenously
Study NCT01482975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tailored computer based intervention
Description: Best practices for TTM tailored communication with two types of feedback: normative - compared to peer and ipsative - self compared to previous assessment.
Study NCT01482975 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tailored computer intervention
Description: Best practices for TTM tailored communication with two types of feedback: normative - compared to peer and ipsative - self compared to previous assessment
Study NCT04210180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Description: 0.5 mg nightly for days 1-3, then 0.5 mg twice daily for days 4-7; then 1 mg twice daily for the remaining 11 weeks.
Study NCT02540499 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: DIBH VMAT
Description: Radiotherapy delivered in deep inspiration breath-hold with volumetric modulated arc therapy technique.
Study NCT03517254 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Glutamine
Description: At the beginning and at the end of the training session, the experimental group will receive by mouth 15 grams of glutamine dissolved in 120 milliliters of water. The aminoacid will be inside gray envelopes.
Study NCT04210180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: e-cigarette
Description: Each G6 prefilled cartomizer contains a 50/50 blend nicotine salt with 35mg nicotine strength.
Study NCT03281382 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad5-yCD/mutTKSR39rep-hIL12
Description: Oncolytic adenovirus expressing two suicide genes and human IL-12
Study NCT03403413 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: muscle vibration during walking
Description: Baseline assessment of gait followed by 12 sessions (3/week for a month) of gait training with cyclic muscle vibration during walking emulating normal muscle activity of lower extremities in treatment group. Gait assessment both with and without muscle vibration were collected at follow-up after 12 sessions of gait training with muscle vibration.
Study NCT01736891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rasagiline
Description: Tablets, qd
Study NCT01736891 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablets, qd
Study NCT04356820 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupressure
Description: Data collection took about 10 to 15 minutes. Then the woman invited to the examination room was asked to pull one of the envelopes with the names of the groups. The women who pulled the acupressure envelope were given a semi-sitting position where the acupressure application can feel comfortable and the researcher can easily apply the acupressure points. Before the acupressure application, massage was applied for 30 seconds to ensure circulation. Afterwards, 90 seconds consecutive pressures were applied to the specified acupressure points in a certain order (SP 6, Li 4), taking into account the direction of the meridian. After the examination, the pain formed during the gynecological examination was evaluated by applying the Short Form-McGill Pain Questionnaire without leaving the examination room
Study NCT03517254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength training program
Description: One training session consists of 20 minutes of warm-up, 40 to 60 minutes of aerobic and anaerobic exercises and 15 minutes of cooling down. The exercises of the lower part of the body consist in 3 sets of 10 repetitions for healthy knee, and 12 repetitions for knee with anterior cruciate ligament reconstruction in a modular leg press, leg curl and leg extension machine.
Study NCT00316953 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dasatinib
Description: Given orally
Study NCT00316953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT00316953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT04367272 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: First Arthroplasty
Description: First Knee
Study NCT04367272 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Second Arthroplasty
Description: Second Knee
Study NCT02545036 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) daycare model
Description: Traditional Chinese Medical (TCM) daycare model provides multiple approaches of traditional Chinese medical treatment, including 5 tones of Chinese music, massage for meridians and collaterals, acupuncture, and patient education. The treatment course is one time a week, for 12 weeks (12 treatments in total).
Study NCT03366870 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computerized Cognitive Behavioral Therapy for Insomnia
Description: A computerized insomnia intervention that employs the same behavioral, educational, and cognitive treatment components that underlie non-computerized CBT-I.
Study NCT03366870 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Education
Description: A web-based program will deliver components of sleep education via an Internet platform.
Study NCT03315585 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: steep pulse device
Description: Applying the steep pulse to treat the patients with Prostate cancer
Study NCT03732469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Rectal acetaminophen will be administered to the intervention group at the conclusion of the oocyte retrieval.
Study NCT03732469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl
Description: Weight-based IV Fentanyl as a part of the standard anesthesia/analgesia induction protocol at Tampa General Hospital
Study NCT03732469 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: Weight-based IV Fentanyl as a part of the standard anesthesia/analgesia induction protocol at Tampa General Hospital
Study NCT03732469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Weight-based IV Propofol as a part of the standard anesthesia/analgesia induction protocol at Tampa General Hospital
Study NCT03732469 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Weight-based IV Propofol as a part of the standard anesthesia/analgesia induction protocol at Tampa General Hospital
Study NCT01903005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Higher bioavailability BNX sublingual tablets
Description: Once daily, open-label treatment with higher bioavailability BNX sublingual tablets for 24 weeks
Study NCT00490581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: case management and supportive housing
Description: patients randomized to the study group are offerred respite care/interim housing and case management upon discharge from enrolling hospitalization. They are also offerred stable housing within 90 days of enrolling hospital discharge, with case management at all 3 stages - hospital, respite care/interim housing, and stable housing.
Study NCT00557037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenoxodiol
Description: Oral capsule, 400 mg every 8 hours daily, for 12 weeks - assement to a maximum of 12 months
Study NCT03517254 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Strength training program
Description: One training session consists of 20 minutes of warm-up, 40 to 60 minutes of aerobic and anaerobic exercises and 15 minutes of cooling down. The exercises of the lower part of the body consist in 3 sets of 10 repetitions for healthy knee, and 12 repetitions for knee with anterior cruciate ligament reconstruction in a modular leg press, leg curl and leg extension machine.
Study NCT03517254 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin powder to mimic glutamine,
Study NCT03517254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary recommendations
Description: All participants, irrespective of the supplement that they receive, will be closely monitored by a nutritionist, who will give dietary recommendations to standardize protein consumption (1.2 gr/kg weight). Status nutritional will be assessed according to BMI ( 19.9-24.9, 25-29.9).
Study NCT03517254 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Dietary recommendations
Description: All participants, irrespective of the supplement that they receive, will be closely monitored by a nutritionist, who will give dietary recommendations to standardize protein consumption (1.2 gr/kg weight). Status nutritional will be assessed according to BMI ( 19.9-24.9, 25-29.9).
Study NCT01634282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OPC-262
Description: Orally administered once daily
Study NCT02667821 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Head positions and spinal manipulation
Description: Each participant will undergo three separate test maneuvers. Neutral (0° rotation) neck position (condition 1) will be followed by block randomization between maximum voluntary rotation (condition 2) and a high-velocity-low-amplitude cervical manipulation targeted at C1-C2 (condition 3). Conditions 1 and 2 will be held for 1 minute before returning to neutral alignment. For the manipulation, the head will be repositioned at neutrality immediate. An experienced practitioner will perform the manipulation on the adjustable and pivotal MRI bed. After each condition, MRI of the upper neck and cerebrum for perfusion and blood flow will ensue.
Study NCT03180801 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: adjuvanted FLU-v
Description: Subcutaneous injection in the upper arm with 500mcg of FLU-v as 0.5ml emulsion in 0.25ml of WFI and 0.25ml of adjuvant Montanide ISA-51
Study NCT03180801 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: adjuvanted placebo
Description: Subcutaneous injection in the upper arm with 0.5ml emulsion made of 0.25ml of WFI and 0.25ml of adjuvant Montanide ISA-51
Study NCT03180801 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: adjuvanted placebo
Description: Subcutaneous injection in the upper arm with 0.5ml emulsion made of 0.25ml of WFI and 0.25ml of adjuvant Montanide ISA-51
Study NCT03180801 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Influenza challenge
Description: On day 0, administration with an intranasal sprayer of 1ml of PBS containing 10(7) TCID50 of Influenza A 2009 H1N1 human virus manufactured under GMP in certified Vero cells.
Study NCT03180801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Influenza challenge
Description: On day 0, administration with an intranasal sprayer of 1ml of PBS containing 10(7) TCID50 of Influenza A 2009 H1N1 human virus manufactured under GMP in certified Vero cells.
Study NCT01996384 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Classical Acupuncture
Description: Very thin needles (0.18mm) will be inserted into locations either on the front or the back of the body and may be placed near or far from the affected area. No needles will be inserted into the genital region. Locations needled will be in classical acupuncture points. On even-numbered visits, the needles may be electrically stimulated via an electro-acupuncture machine. Needles will be retained for 30 minutes per study visit. Acupuncture needles used are 0.18x30-40mm, manufactured by Dong Bae Corporation (DBC), Korea. The electrical acupuncture device is Pantheon Research Electrical Stimulator 8c, United States.
Study NCT01996384 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-classical acupuncture
Description: Very thin needles (0.18mm) will be inserted into locations either on the front or the back of the body and may be placed near or far from the affected area. No needles will be inserted into the genital region. Locations needled will be in non-classical acupuncture points. On even-numbered visits, the needles may be electrically stimulated via an electro-acupuncture machine. Needles will be retained for 30 minutes per study visit. Acupuncture needles used are DBC Brand, Korea, 0.18x30-40mm. The electrical acupuncture device is Pantheon Research Electrical Stimulator 8c, United States.
Study NCT01996384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: Study participants will gently apply 5% lidocaine cream four times daily to vulvar area.
Study NCT01996384 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: Study participants will gently apply 5% lidocaine cream four times daily to vulvar area.
Study NCT04300413 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-Intensity Rehabilitation plus Mobility (HeRo)
Description: Progressive, high-intensity strengthening and functional intervention coupled with structured mobility based in principals of behavioral economics.
Study NCT02350374 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: carbohydrate counting
Description: patients must fill their logbook with the following data:~* cho amount at breakfast, lunch, snack and dinner~* insulin amount at breakfast, lunch, snack and dinner
Study NCT04641793 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Motion and Emg Control
Description: We will consider two methods for integrating motions and EMG signals:~1. Direct methods. Signals extracted from the latent EMG space will directly contribute to the control of the external device. We will integrate EMG and IMU in two ways. In a first scenario, EMG and IMU will be given variable weight in the control. In a second scenario (perturbative method) the distance of ongoing muscle patterns from a desired set of strategies will modulate the mapping from body to cursor motions in the form of assistive (i.e. the cursor moves faster towards the target) or resistive (i.e. the cursor slows down) influences on cursor movement.~2. Indirect Methods. Signals extracted by EMG will modulate the feedback offered to the learner to penalize deviations from desired muscle patterns. When multiple ways to perform a movement are offered by redundancy, (i.e., by the multiplicity of muscles compared to task demands), the brain chooses solutions that minimize noise and uncertainty.
Study NCT01214837 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Description: This group received a 3-dose primary series at 2, 4, and 6 months of age and a toddler dose at 12 months of age. Approximately half of the subjects had serum collected at Month 3, and the remainder had serum collected at Month 4.
Study NCT01214837 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Description: This group received a 2-dose primary series at 2 and 4 months of age and a toddler dose at 12 months of age.
Study NCT01214837 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Routine Vaccines
Description: Each 0.5 mL dose of the pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) is formulated to contain approximately 2.2 μg of each of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F saccharides.
Study NCT01214837 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Routine Vaccines
Description: Each 0.5 mL dose of the pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) is formulated to contain approximately 2.2 μg of each of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F saccharides.
Study NCT03671811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Megestrol Acetate
Description: Given PO
Study NCT01373346 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Long limb Roux-en Y reconstruction
Description: After radical gastrectomy, the gastrointestinal tract was reconstructed by Roux-en-Y gastrojejunostomy or esophagojejunostomy. The jejunum was divided at approximately 100-120 cm distal to the ligament of Treitz and the distal limb of the jejunum was then anastomosed along the proximal gastric greater curvature or esophagus. The jejuno-jejunostomy was performed approximately 100 to 120 cm distal from the gastrojejunal or esophagojejunal anastomosis
Study NCT00979537 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nisoldipine Extended-release Tablets, 40 mg
Study NCT00979537 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sular Tablets, 40 mg
Study NCT03671811 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pterostilbene
Description: Given PO
Study NCT02178176 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education, encouragement, card sort
Description: Patients will identify factors involved in nonadherence. For each factor influencing adherence, the interventionist will engage the patient in a 4-step problem solving process.~We will recognize patients' social and cultural context by addressing health-related priorities identified by the patient. The goal will be to identify those priorities which are likely to influence engagement in care and adherence to treatment. We will assess both biomedical (physical symptoms, diet and exercise) and nonbiomedical (financial, social and emotional) needs patients with Type 2 diabetes mellitus and depressive symptoms may wish to discuss in the context of their health. After the patients complete the card sort, interventionists will engage the patient in the 4-step problem solving process.